Postneoadjuvant adjuvant chemotherapy in resected N1 non‐small cell lung cancer with residual nodal disease

E-ISSN： 1096-9098|116|8|1193-1196

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.116, Iss.8, 2017-12, pp. : 1193-1196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of age on the efficacy of adjuvant chemotherapy for resected non–small cell lung cancer

CANCER, Vol. 121, Iss. 15, 2015-08 ,pp. : 2578-2585

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use and impact of adjuvant chemotherapy in patients with resected non‐small cell lung cancer

CANCER, Vol. 120, Iss. 13, 2014-07 ,pp. : 1939-1947

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of DNA Repair Gene Polymorphisms in the Efficiency of Platinum-Based Adjuvant Chemotherapy for Non-Small Cell Lung Cancer

By Mathiaux Juliette >

Molecular Diagnosis & Therapy, Vol. 15, Iss. 3, 2011-06 ,pp. : 159-166

Adis International

Access to resources Recommend Favorite

Impact and Safety of Adjuvant Chemotherapy on Pulmonary Function in Early Stage Non-Small Cell Lung Cancer

Respiration, Vol. 87, Iss. 3, 2013-10 ,pp. : 204-210

Karger

Access to resources Recommend Favorite

Paclitaxel, Carboplatin and Gemcitabine Combination as Induction Chemotherapy for Stage IIIA N2 Bulky Non-Small Cell Lung Cancer

Oncology, Vol. 69, Iss. 4, 2005-12 ,pp. : 295-300

Karger

Access to resources Recommend Favorite